Should You Buy ATAI Life Sciences NV (ATAI) Stock Monday Morning?

ATAI Life Sciences NV (ATAI) has risen Monday morning, with the stock gaining 5.88% in pre-market trading to 4.5. ATAI's short-term technical score of 5 indicates that the stock has traded less bullishly over the last month than 95% of stocks on the market. In the Biotechnology industry, which ranks 131 out of 146 industries, the stock ranks higher than 7% of stocks. ATAI Life Sciences NV has risen 30.77% over the past month, closing at $3.36 on June 20. During this period of time, the stock fell as low as $3.36 and as high as $4.38. ATAI has an average analyst recommendation of Strong Buy. The company has an average price target of $24.67.

ATAI has an Overall Score of 46. Find out what this means to you and get the rest of the rankings on ATAI!

See Full ATAI Report

ATAI Life Sciences NV has a Long-Term Technical rank of 49. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 51% of the market scoring higher. In the Biotechnology industry which is number 50 by this metric, ATAI ranks better than 50% of stocks.

Important Dates for Investors in ATAI:

-ATAI Life Sciences NV is set to release earnings on 8/15/2022. Over the last 12 months, the company has reported EPS of $-1.44. -We do not have a set dividend date for ATAI Life Sciences NV at this time. Click Here To Get The Full Report on ATAI Life Sciences NV (ATAI)